370 related articles for article (PubMed ID: 24585742)
21. The muscle-relaxing C-terminal peptide from troponin I populates a nascent helix, facilitating binding to tropomyosin with a potent therapeutic effect.
Hornos F; Feng HZ; Rizzuti B; Palomino-Schätzlein M; Wieczorek D; Neira JL; Jin JP
J Biol Chem; 2021; 296():100228. PubMed ID: 33814345
[TBL] [Abstract][Full Text] [Related]
22. Modifications of Sarcoplasmic Reticulum Function Prevent Progression of Sarcomere-Linked Hypertrophic Cardiomyopathy Despite a Persistent Increase in Myofilament Calcium Response.
Chowdhury SAK; Warren CM; Simon JN; Ryba DM; Batra A; Varga P; Kranias EG; Tardiff JC; Solaro RJ; Wolska BM
Front Physiol; 2020; 11():107. PubMed ID: 32210830
[TBL] [Abstract][Full Text] [Related]
23. Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy.
Lehman SJ; Tal-Grinspan L; Lynn ML; Strom J; Benitez GE; Anderson ME; Tardiff JC
Circulation; 2019 Mar; 139(12):1517-1529. PubMed ID: 30586744
[TBL] [Abstract][Full Text] [Related]
24. Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.
Dweck D; Sanchez-Gonzalez MA; Chang AN; Dulce RA; Badger CD; Koutnik AP; Ruiz EL; Griffin B; Liang J; Kabbaj M; Fincham FD; Hare JM; Overton JM; Pinto JR
J Biol Chem; 2014 Aug; 289(33):23097-23111. PubMed ID: 24973218
[TBL] [Abstract][Full Text] [Related]
25. Myofilament calcium sensitivity and cardiac disease: insights from troponin I isoforms and mutants.
Westfall MV; Borton AR; Albayya FP; Metzger JM
Circ Res; 2002 Sep; 91(6):525-31. PubMed ID: 12242271
[TBL] [Abstract][Full Text] [Related]
26. Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy.
Schulz EM; Wilder T; Chowdhury SA; Sheikh HN; Wolska BM; Solaro RJ; Wieczorek DF
J Biol Chem; 2013 Oct; 288(40):28925-35. PubMed ID: 23960072
[TBL] [Abstract][Full Text] [Related]
27. Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an alpha-tropomyosin mutation linked to familial hypertrophic cardiomyopathy.
Burkart EM; Arteaga GM; Sumandea MP; Prabhakar R; Wieczorek DF; Solaro RJ
J Mol Cell Cardiol; 2003 Oct; 35(10):1285-93. PubMed ID: 14519438
[TBL] [Abstract][Full Text] [Related]
28. Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation.
Messer AE; Bayliss CR; El-Mezgueldi M; Redwood CS; Ward DG; Leung MC; Papadaki M; Dos Remedios C; Marston SB
Arch Biochem Biophys; 2016 Jul; 601():113-20. PubMed ID: 27036851
[TBL] [Abstract][Full Text] [Related]
29. Structural and Functional Effects of Cardiomyopathy-Causing Mutations in the Troponin T-Binding Region of Cardiac Tropomyosin.
Matyushenko AM; Shchepkin DV; Kopylova GV; Popruga KE; Artemova NV; Pivovarova AV; Bershitsky SY; Levitsky DI
Biochemistry; 2017 Jan; 56(1):250-259. PubMed ID: 27983818
[TBL] [Abstract][Full Text] [Related]
30. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
Karibe A; Tobacman LS; Strand J; Butters C; Back N; Bachinski LL; Arai AE; Ortiz A; Roberts R; Homsher E; Fananapazir L
Circulation; 2001 Jan; 103(1):65-71. PubMed ID: 11136687
[TBL] [Abstract][Full Text] [Related]
31. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
[TBL] [Abstract][Full Text] [Related]
32. The evolutionarily conserved C-terminal peptide of troponin I is an independently configured regulatory structure to function as a myofilament Ca
Wong S; Feng HZ; Jin JP
J Mol Cell Cardiol; 2019 Nov; 136():42-52. PubMed ID: 31505197
[TBL] [Abstract][Full Text] [Related]
33. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
[TBL] [Abstract][Full Text] [Related]
34. Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes.
Schuldt M; Johnston JR; He H; Huurman R; Pei J; Harakalova M; Poggesi C; Michels M; Kuster DWD; Pinto JR; van der Velden J
J Mol Cell Cardiol; 2021 Jan; 150():77-90. PubMed ID: 33148509
[TBL] [Abstract][Full Text] [Related]
35. Microarray analysis of active cardiac remodeling genes in a familial hypertrophic cardiomyopathy mouse model rescued by a phospholamban knockout.
Rajan S; Pena JR; Jegga AG; Aronow BJ; Wolska BM; Wieczorek DF
Physiol Genomics; 2013 Sep; 45(17):764-73. PubMed ID: 23800848
[TBL] [Abstract][Full Text] [Related]
36. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
[TBL] [Abstract][Full Text] [Related]
37. Molecular Defects in Cardiac Myofilament Ca
Sheehan A; Messer AE; Papadaki M; Choudhry A; Kren V; Biedermann D; Blagg B; Khandelwal A; Marston SB
Front Physiol; 2018; 9():243. PubMed ID: 29636697
[TBL] [Abstract][Full Text] [Related]
38. In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene.
Martins AS; Parvatiyar MS; Feng HZ; Bos JM; Gonzalez-Martinez D; Vukmirovic M; Turna RS; Sanchez-Gonzalez MA; Badger CD; Zorio DAR; Singh RK; Wang Y; Jin JP; Ackerman MJ; Pinto JR
Circ Cardiovasc Genet; 2015 Oct; 8(5):653-664. PubMed ID: 26304555
[TBL] [Abstract][Full Text] [Related]
39. Rat cardiac troponin T mutation (F72L)-mediated impact on thin filament cooperativity is divergently modulated by α- and β-myosin heavy chain isoforms.
Chandra V; Gollapudi SK; Chandra M
Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1260-70. PubMed ID: 26342069
[TBL] [Abstract][Full Text] [Related]
40. Functional consequences of the deletion mutation deltaGlu160 in human cardiac troponin T.
Harada K; Takahashi-Yanaga F; Minakami R; Morimoto S; Ohtsuki I
J Biochem; 2000 Feb; 127(2):263-8. PubMed ID: 10731693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
